Abstract
Homeostatic immune regulatory mechanisms can mediate premature termination of therapy-induced antitumor T-effector cell responses. Administration of cyclophosphamide (CY) prior to intratumoral IL-12 and GM-CSF delivery blocked post-treatment T-suppressor cell rebound via elimination of the pre-existing T-suppressor cell pool, allowed repeated activation of antitumor cytotoxic T-cells and resulted in the cure of advanced spontaneous tumors. © 2012 Landes Bioscience.
Author supplied keywords
Cite
CITATION STYLE
Egilmez, N. K., Harden, J. L., & Rowswell-Turner, R. B. (2012). Chemoimmunotherapy as long-term maintenance therapy for cancer. OncoImmunology, 1(4), 563–565. https://doi.org/10.4161/onci.19369
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.